Table 3 Aggregate hospital costs of lung cancer diagnosis and treatment by stage at diagnosis and cost type (Euros, 2008)

NSCLC (sum, %)

Stage I

28,573

306,114

27,280

12,755

102,652

42,153

519,526

5.5%

58.9%

5.3%

2.5%

19.8%

8.1%

100.0%

Stage II

16,106

81,416

27,624

6,538

32,288

13,348

177,320

9.1%

45.9%

15.6%

3.7%

18.2%

7.5%

100.0%

Stage III

119,463

71,598

98,958

25,969

128,901

30,957

475,846

25.1%

15.0%

20.8%

5.5%

27.1%

6.5%

100.0%

Stage IV

287,012

22,863

488,195

23,205

227,928

18,930

1,068,133

26.9%

2.1%

45.7%

2.2%

21.3%

1.8%

100.0%

Unknown

71,792

98,615

111,030

900

15,828

9,670

307,835

23.3%

32.0%

36.1%

0.3%

5.1%

3.1%

100.0%

Total (N = 172)

522,946

580,605

753,087

69,367

507,597

115,058

2,548,661

20.5%

22.8%

29.5%

2.7%

19.9%

4.5%

100.0%

SCLC (sum, %)

Limited disease

11,822

-

33,959

11,699

42,933

7,516

107,929

11.0%

31.5%

10.8%

39.8%

7.0%

100.0%

Extensive disease

45,011

-

83,077

10,928

48,729

11,962

199,707

22.5%

41.6%

5.5%

24.4%

6.0%

100.0%

Unknown

14,584

-

67

-

1,266

526

16,444

88.7%

0.4%

7.7%

3.2%

100.0%

Total (N = 26)

71,417

-

117,103

22,627

92,928

20,005

324,079

22.0%

36.1%

7.0%

28.7%

6.2%

100.0%

NCC (sum, %)

Stage I

2,195

16,844

-

-

83,428

701

103,168

2.1%

16.3%

80.9%

0.7%

100.0%

Stage II

-

-

-

-

-

-

-

Stage III

8,122

-

7,400

-

5,875

1,880

23,277

34.9%

31.8%

25.2%

8.1%

100.0%

Stage IV

58,543

7,835

81,106

4,747

32,462

2,973

187,665

31.2%

4.2%

43.2%

2.5%

17.3%

1.6%

100.0%

Unknown

62,873

10,660

2,335

-

20,794

1,698

98,360

63.9%

10.8%

2.4%

21.1%

1.7%

100.0%

Total (N = 34)

131,734

35,339

90,841

4,747

142,559

7,252

412,472

31.9%

8.6%

22.0%

1.2%

34.6%

1.8%

100.0%